Document is current
Any future updates will be listed below
-
Authors
Fang, Chuling https://orcid.org/0000-0002-8381-1823
Wang, Lixin
Zhao, Weiqiang
Wang, Lei
Huang, Wenfa
Chen, Ziren
Wang, Yiran
Tan, Kun
Guo, Xiao
Xu, Yuanyuan
Wang, Shuhong
Wang, Lijun
Qiao, Jingqiao
Meng, Xiangyu
He, Ziqian
Yu, Chuan
Mei, Junhui
Wang, Hongxin
Li, Yisheng
-
Funding
Funding for this research was provided by:
Chinese National Major Project for New Drug Innovation (2019ZX09201002003)
National Natural Science Foundation of China (82030076, 82070161, 81970151, 81670162 and 81870134)
Shenzhen Clinical Research Center for hematologic disease (LCYSSQ20220823091401002)
Shenzhen Science and Technology Foundation (JCYJ20190808163601776, JCYJ20200109113810154)
Shenzhen Key Laboratory (ZDSYS20200811143757022)
Sanming Project of Medicine in Shenzhen (SZSM202111004)
Natural Science Foundation of Shenzhen University General Hospital (SUGH2019QD012)
Shenzhen Natural Science Fund (20200830182623001)
HaiYa Young Scientist Foundation of Shenzhen University General Hospital (HY002)
Shenzhen Medical Research Fund (C2301003)
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 7 September 2025
First Online: 10 November 2025
Declarations
:
: This study was approved by the ethics committee of Shenzhen University General Hospital and was registered with ClinicalTrials.gov (NCT05150522). Informed consent was obtained from all enrolled patients.
: The authors have obtained consent to publish from the participant to report patient data.
: The authors declare no potential conflicts of interest.
